Alzheimer's Disease Trial, Recruiting NCT06183658 Sponsor: Shenzhen Bay Laboratory Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06183658
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 55 and 90 years old (people with a known inherited form of Alzheimer's disease in the family may not be limited by age — confirm with trial site)
  • You scored less than 6 points on a standard depression screening questionnaire called the Geriatric Depression Scale
  • You have a caregiver who can spend at least 10 hours per week with you and can travel with you to the study location for appointments
  • Your vision and hearing are good enough (with glasses or hearing aids if needed) to complete memory and thinking tests
  • You are generally in good health and expected to stay well enough to participate throughout the study
  • You are not pregnant, breastfeeding, or able to become pregnant (women must be at least two years past menopause or have had sterilisation surgery)
  • You are willing and able to take part in brain imaging sessions over a period of time
  • You scored 4 or below on a standard test used to assess blood supply problems in the brain (confirm with trial site)
  • You have completed at least 6 years of schooling, or have enough work experience to show you do not have an intellectual disability
  • You can speak Mandarin fluently
  • You are willing to have multiple MRI brain scans and at least two PET scans
  • You agree to give blood samples for genetic analysis, including tests for genes related to Alzheimer's disease risk, and for those samples to be stored and shared
  • You agree to give blood samples for biomarker testing and to have those results shared

Who may not be able to join:

  • A brain MRI scan shows signs of infection, stroke, or other significant damage to the brain
  • You cannot have an MRI scan for any reason, such as having a pacemaker, or any metal implants or fragments in your body, eyes, or skin
  • You have had severe depression or bipolar disorder in the past year
  • You have had significant behavioural problems, agitation, or symptoms of psychosis in the past 3 months that might make it hard to follow the study requirements
  • You are currently taking medication for obsessive-compulsive disorder or attention deficit disorder
  • You have a history of schizophrenia
  • You have had problems with alcohol or drug misuse or dependence in the past 2 years
  • You have a serious ongoing physical illness or unstable health condition that could make it difficult to stay in a long-term study
  • You have significantly abnormal levels of vitamin B12 or thyroid function that could affect the study (low B12 will lead to exclusion)
  • You are currently taking certain medications that affect the brain or mood, such as certain antidepressants, antipsychotics, regular anxiety medication, or sleeping tablets; or you are taking blood-thinning medications such as warfarin, dabigatran, rivaroxaban, or apixaban (confirm with trial site for exceptions)
  • You are currently using prohibited substances (confirm with trial site for details)
  • You are currently taking part in another clinical trial related to brain or mental health

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shenzhen Bay Laboratory
Registry
ClinicalTrials.gov
Start date
1 May 2021
Est. completion
30 April 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Longitudinal changes of cognitive function _ ADAS-Cog; Longitudinal changes of cognitive function _ MMSE, the Chinese version; Longitudinal changes of cognitive function _ MoCA-Basic; Longitudinal functional and behavioral function _ CDR; Longitudinal functional and behavioral function _ NPI; Longitudinal functional and behavioral function _ GDS; Longitudinal functional and behavioral function _ FAQ; Longitudinal functional and behavioral function _ ADL; Longitudinal functional and behavioral function _ PSQI; Longitudinal functional and behavioral function _ RBDSQ

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov